You're not logged in. Please log in to earn stock or Bitcoin rewards on your prescription purchase.
Basaglar KwikPen
Basaglar KwikPen is a long-acting insulin used to help control blood sugar levels in people with diabetes mellitus. It contains insulin glargine, a recombinant human insulin analog that provides a steady, prolonged glucose-lowering effect. Basaglar is typically used in adults and children with type 1 diabetes and adults with type 2 diabetes. The KwikPen is a prefilled, disposable insulin pen that is easy to use and allows for precise dosing.
Drug Availability and Controlled Substance Status
Basaglar KwikPen is available by prescription only and is not classified as a controlled substance. It is supplied as a prefilled pen containing 3 mL of solution with a concentration of 100 units/mL.
Rx. Enter your prescription
How would you like to get your prescription? Select an option
Pharmacy pickup
Select from 35,000 pharmacies
Free two-day delivery
Coming soon!
Find a pharmacy near you. Enter your ZIP code
Are you a member? Sign up or log in.
Members have saved
$NaN
using our savings card for instant savings.
Don't pay full retail price and miss out on potential savings. Try it now—you have nothing to lose!
NaNM
worth of Satoshi has been rewarded to our members.
Everyone who signs up enjoys the benefits of earning FREE Bitcoin with every purchase.
How much Bitcoin can you earn with Basaglar KwikPen ?
The potential for Bitcoin rewards to increase and appreciate in value is a possibility to consider, which may occur over time.
See the value of your savings today
Today's Value
1 Bitcoin = $NaN
Bitcoin (BTC)
...
USD
$NaN
Adjust Bitcoin's potential value to see how much it could be worth
Potential Value
1 Bitcoin =
Bitcoin (BTC)
...
USD
$NaN
Frequently Asked Questions
How long does it take for Basaglar to start working?
Basaglar starts working within a few hours of injection, with a peakless effect that lasts up to 24 hours, providing consistent blood sugar control throughout the day and night.
Can I use Basaglar KwikPen with other insulins?
Basaglar can be used in combination with other insulins, such as rapid-acting insulin for mealtime blood sugar control. However, it should not be mixed with other insulins in the same syringe or pen.
What should I do if I miss a dose of Basaglar?
If you miss a dose of Basaglar, take it as soon as you remember, but not if it’s almost time for your next dose. Do not take an extra dose to make up for the missed one. Monitor your blood glucose levels closely and follow your healthcare provider’s advice.
Is Basaglar KwikPen safe to use during pregnancy?
Insulin is the preferred treatment for managing diabetes during pregnancy. Basaglar is generally considered safe for use during pregnancy, but it’s essential to manage blood glucose levels carefully. Pregnant women should consult their healthcare provider to ensure proper dosing and monitoring.
Can I travel with Basaglar KwikPen?
Yes, you can travel with Basaglar KwikPen. Keep it in its original packaging, carry it in your hand luggage, and ensure it stays at the appropriate temperature. If traveling across time zones, consult your healthcare provider to adjust your dosing schedule if needed.
Comprehensive Drug Guide
How Does Basaglar KwikPen Work?
Insulin glargine, the active ingredient in Basaglar, works by regulating glucose metabolism. It lowers blood glucose levels by facilitating cellular uptake of glucose in muscle and fat tissues and inhibiting glucose production in the liver. Unlike short-acting insulins, insulin glargine has a prolonged duration of action, providing stable blood sugar control throughout the day and night with once-daily dosing.
What is Basaglar KwikPen Used For?
Common Dosages
The dosage of Basaglar KwikPen varies depending on the individual’s needs, glucose levels, and other factors:
- Starting Dose: For insulin-naïve patients with type 2 diabetes, a common starting dose is 10 units once daily. For patients transitioning from other insulins, the dose is typically based on the previous insulin regimen.
- Adjustment: Dosage adjustments are made based on blood glucose monitoring results, typically by 1 to 2 units at a time.
Typical Dosing
FDA Approved Indications
Basaglar KwikPen is FDA-approved for:
- Type 1 Diabetes Mellitus: In adults and pediatric patients requiring basal insulin for glycemic control.
- Type 2 Diabetes Mellitus: In adults who need basal insulin to control hyperglycemia.
Who Shouldn't Take Basaglar KwikPen?
Basaglar KwikPen is contraindicated in patients with:
- Hypersensitivity to insulin glargine or any other component of the product.
- Episodes of hypoglycemia (low blood sugar), as it is crucial to treat hypoglycemia before administering Basaglar.
Advice From The Pharmacist
Patients using Basaglar KwikPen should be advised to:
- Monitor their blood glucose levels regularly and adjust their insulin dose as recommended by their healthcare provider.
- Be aware of the signs and symptoms of hypoglycemia, such as dizziness, sweating, shaking, or confusion, and know how to treat it quickly (e.g., consuming fast-acting sugar).
- Keep a source of fast-acting sugar (e.g., glucose tablets, juice) available at all times.
- Rotate injection sites to prevent skin changes (lipodystrophy).
- Avoid alcohol, which can affect blood sugar levels and increase the risk of hypoglycemia.
- Ensure they know how to use the KwikPen correctly, including how to attach needles, select the dose, and inject the insulin.
Side Effects of Basaglar KwikPen
Common Side Effects
Common side effects of Basaglar KwikPen may include:
- Hypoglycemia (low blood sugar), the most common side effect of insulin therapy
- Injection site reactions, such as redness, swelling, or itching
- Weight gain, which can occur with long-term insulin use
Uncommon/Severe Side Effects
Serious side effects can include:
- Severe Hypoglycemia: Symptoms include confusion, seizures, loss of consciousness, or even death if untreated.
- Allergic Reactions: Such as rash, itching, swelling, or anaphylaxis, although these are rare.
- Lipodystrophy: Abnormal changes in the fatty tissue under the skin at the injection site.
Risks and Warnings of Basaglar KwikPen
- Hypoglycemia: The most significant risk associated with Basaglar is hypoglycemia. Patients must monitor their blood sugar levels closely, particularly when there are changes in physical activity, diet, or insulin regimen.
- Hyperglycemia and Ketoacidosis: Improper dosing, skipped doses, or issues with the pen can lead to high blood sugar and potentially diabetic ketoacidosis, a life-threatening condition.
- Interaction with Other Medications: Certain medications can affect insulin action and increase the risk of hypoglycemia or hyperglycemia.
Interactions with Basaglar KwikPen
Common Drug Interactions
Basaglar KwikPen may interact with other medications, including:
- Oral Antidiabetic Drugs: Such as sulfonylureas, which can increase the risk of hypoglycemia when used with insulin.
- Beta-Blockers: Can mask the symptoms of hypoglycemia, making it harder to recognize low blood sugar.
- Corticosteroids: Can increase blood glucose levels, potentially requiring a higher insulin dose.
- ACE Inhibitors: May enhance insulin sensitivity and increase the risk of hypoglycemia.
Patients should inform their healthcare provider of all medications and supplements they are taking to avoid potential interactions.
Alternatives to Basaglar KwikPen
Alternative treatments for diabetes management include:
- Other Long-Acting Insulins: Such as insulin detemir (Levemir) or insulin degludec (Tresiba), which provide similar basal insulin coverage.
- Intermediate-Acting Insulin: Such as NPH insulin, which requires twice-daily dosing.
- Insulin Pumps: For continuous subcutaneous insulin infusion, which can offer more precise control over blood glucose levels.
- Oral Antidiabetic Medications: Such as metformin, GLP-1 agonists, or SGLT2 inhibitors for type 2 diabetes management.
The choice of treatment depends on the individual’s specific condition, treatment goals, and lifestyle preferences.
